1BU Stock Overview
Avant Brands Inc. cultivates, produces, and markets cannabis products in Canada.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Avant Brands Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.68 |
| 52 Week High | CA$4.17 |
| 52 Week Low | CA$0.52 |
| Beta | 3.28 |
| 11 Month Change | -11.22% |
| 3 Month Change | -44.03% |
| 1 Year Change | -80.79% |
| 33 Year Change | -92.68% |
| 5 Year Change | -85.38% |
| Change since IPO | -91.51% |
Recent News & Updates
Recent updates
Shareholder Returns
| 1BU | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | -4.2% | 1.7% | 1.8% |
| 1Y | -80.8% | -11.1% | 13.8% |
Return vs Industry: 1BU underperformed the German Pharmaceuticals industry which returned -11.1% over the past year.
Return vs Market: 1BU underperformed the German Market which returned 13.8% over the past year.
Price Volatility
| 1BU volatility | |
|---|---|
| 1BU Average Weekly Movement | 26.5% |
| Pharmaceuticals Industry Average Movement | 5.4% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 11.1% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 1BU's share price has been volatile over the past 3 months.
Volatility Over Time: 1BU's weekly volatility (27%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 180 | Norton Singhavon | www.avantbrands.ca |
Avant Brands Inc. cultivates, produces, and markets cannabis products in Canada. The company offers medical and recreational cannabis products under the BLK MKT, Tenzo, GreenTec, cognoscente, Treehugger, Pristine, and Flowr brands. It distributes cannabis through medical and recreational sales channels, as well as an e-commerce website.
Avant Brands Inc. Fundamentals Summary
| 1BU fundamental statistics | |
|---|---|
| Market cap | €7.35m |
| Earnings (TTM) | -€7.54m |
| Revenue (TTM) | €18.56m |
0.4x
P/S Ratio-1.0x
P/E RatioIs 1BU overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1BU income statement (TTM) | |
|---|---|
| Revenue | CA$27.70m |
| Cost of Revenue | CA$22.53m |
| Gross Profit | CA$5.17m |
| Other Expenses | CA$16.43m |
| Earnings | -CA$11.26m |
Last Reported Earnings
May 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.07 |
| Gross Margin | 18.66% |
| Net Profit Margin | -40.65% |
| Debt/Equity Ratio | 13.6% |
How did 1BU perform over the long term?
See historical performance and comparison